Keywords
ExcitotoxicityGlutamate receptorNeuroscienceNeuropathologyNMDA receptorNeurodegenerationAlzheimer's diseaseCholinergicMedicineBiologyReceptorDiseaseInternal medicine
Affiliated Institutions
Related Publications
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Many potential treatments for Alzheimer's disease target amyloid-β peptides (Aβ), which are widely presumed to cause the disease. The microtubule-associated protein tau is also ...
Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Alzheimer's disease (AD), the most common neurodegenerative disorder, is a growing public health problem and still lacks effective treatments. Recent evidence suggests that micr...
Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration
Abstract Using a human amyloid β (Aβ) intracerebroventricular infusion mouse model of Alzheimer's disease‐related injury, we previously demonstrated that systemic administration...
Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTP<i>In Vivo</i>Is Prevented by Immunotargeting Cellular Prion Protein
Synthetic amyloid-β protein (Aβ) oligomers bind with high affinity to cellular prion protein (PrP C ), but the role of this interaction in mediating the disruption of synaptic p...
Publication Info
- Year
- 2004
- Type
- review
- Volume
- 45
- Issue
- 5
- Pages
- 583-595
- Citations
- 923
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
923
OpenAlex
Cite This
Matthew R. Hynd
(2004).
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer?s disease.
Neurochemistry International
, 45
(5)
, 583-595.
https://doi.org/10.1016/j.neuint.2004.03.007
Identifiers
- DOI
- 10.1016/j.neuint.2004.03.007